Cargando…
小细胞肺癌肿瘤组织及血清CD44表达及临床预后意义
BACKGROUND AND OBJECTIVE: Small cell lung cancer (SCLC) is a highly aggressive malignancy characterized by rapid growth, early metastasis and acquired therapeutic resistance, and the prognosis is extremely poor. Studies have proved that the stem cell marker CD44 is correlated with tumor recurrence a...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387646/ https://www.ncbi.nlm.nih.gov/pubmed/34187156 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.104.10 |